June 12, 2025
Aetna recently announced changes coming to commercial plan drug lists and the launch of a Combined Benefit Management Drug List, which moves five drugs to pharmacy-only coverage on July 1.
The Infusion Providers Alliance (IPA) opposes specialty-pharmacy (white bag) mandates which can have harmful consequences to patients and impose financial and operational strain on providers. IPA sent a letter to Aetna on June 12, 2025, calling for Aetna to immediately reverse this policy change and preserve medical benefit access to these drugs when administered by in-network providers in a physician’s office or infusion center.
About the Infusion Providers Alliance
The Infusion Providers Alliance (IPA) is committed to protecting the integrity of the provider-patient relationship by empowering providers and patients to choose the most appropriate treatment together. We advocate for policies that ensure timely and adequate patient access to high quality care in IPA members’ convenient, community-based, non-hospital settings. IPA members operate over 1,000 in-office or stand-alone ambulatory infusion centers across 43 states nationwide, delivering value to the health care system and improved outcomes to patients.
All inquiries should be emailed to ewarren@infusionprovidersalliance.org.